MercadoLibre (MELI) Q2 Earnings Report Preview: What To Look For
MercadoLibre beat analysts' revenue expectations by 8.1% last quarter, reporting revenues of $5.94 billion, up 37% year on year. It was a strong quarter for the company, with an impressive beat of analysts' EBITDA estimates and impressive growth in its users. It reported 66.6 million daily active users, up 24.5% year on year.
Is MercadoLibre a buy or sell going into earnings? Read our full analysis here, it's free.
This quarter, analysts are expecting MercadoLibre's revenue to grow 28.9% year on year to $6.54 billion, slowing from the 41.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $11.75 per share.
Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 3 downward revisions over the last 30 days (we track 7 analysts). MercadoLibre has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 7.9% on average.
Looking at MercadoLibre's peers in the online marketplace segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Shutterstock delivered year-on-year revenue growth of 21.3%, beating analysts' expectations by 7.5%, and eBay reported revenues up 6.1%, topping estimates by 3.1%. Shutterstock's stock price was unchanged after the resultswhile eBay was up 18.5%.
Read our full analysis of Shutterstock's results here and eBay's results here.
Investors in the online marketplace segment have had steady hands going into earnings, with share prices flat over the last month. MercadoLibre is down 4.6% during the same time and is heading into earnings with an average analyst price target of $2,856 (compared to the current share price of $2,385).
Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Nvidia's ‘most underappreciated' business is taking off like a 'rocket ship'
When Nvidia (NVDA) reports its second quarter earnings on Aug. 27, investors will focus squarely on the company's data center results. After all, that's where the chip giant realizes revenue on the sale of its high-powered AI processors. But the Data Center segment includes more than just chip sales. It also accounts for some of Nvidia's most important, though often overlooked, offerings: its networking technologies. Composed of its NVLink, InfiniBand, and Ethernet solutions, Nvidia's networking products are what allow its chips to communicate with each other, let servers talk to each other inside massive data centers, and ultimately ensure end users can connect to it all to run AI applications. 'The most important part in building a supercomputer is the infrastructure. The most important part is how you connect those computing engines together to form that larger unit of computing,' explained Gilad Shainer, senior vice president of networking at Nvidia. That also translates into some big sales. Nvidia's networking sales accounted for $12.9 billion of its $115.1 billion in data center revenue in its prior fiscal year. That might not seem impressive when you consider that chip sales brought in $102.1 billion, but it eclipses the $11.3 billion that Nvidia's second-largest segment, Gaming, took in for the year. In Q1, networking made up $4.9 billion of Nvidia's $39.1 billion in data center revenue. And it'll continue to grow as customers continue to build out their AI capacity, whether that's at research universities or massive data centers. 'It is the most underappreciated part of Nvidia's business, by orders of magnitude,' Deepwater Asset Management managing partner Gene Munster told Yahoo Finance. 'Basically, networking doesn't get the attention because it's 11% of revenue. But it's growing like a rocket ship.' Connecting thousands of chips When it comes to the AI explosion, Nvidia senior vice president of networking Kevin Deierling says the company has to work across three different types of networks. The first is its NVLink technology, which connects GPUs to each other within a server or multiple servers inside of a tall, cabinet-like server rack, allowing them to communicate and boost overall performance. Then there's InfiniBand, which connects multiple server nodes across data centers to form what is essentially a massive AI computer. Then there's the front-end network for storage and system management, which uses Ethernet connectivity. 'Those three networks are all required to build a giant AI-scale, or even a moderately sized enterprise-scale, AI computer,' Deierling explained. The purpose of all of these various connections isn't just to help chips and servers communicate, though. They're also meant to allow them to do so as fast as possible. If you're trying to run a series of servers as a single unit of computing, they need to talk to each other in the blink of an eye. A lack of data going to GPUs slows the entire operation, delaying other processes and impacting the overall efficiency of an entire data center. '[Nvidia is a] very different business without networking,' Munster explained. 'The output that the people who are buying all the Nvidia chips [are] desiring wouldn't happen if it wasn't for their networking. ' And as companies continue to develop larger AI models and autonomous and semi-autonomous agentic AI capabilities that can perform tasks for users, making sure those GPUs work in lockstep with each other becomes increasingly important. That's especially true as inferencing — running AI models — requires more powerful data center systems. Inferencing powers up The AI industry is in the midst of a broad reordering around the idea of inferencing. At the onset of the AI explosion, the thinking was that training AI models would require hugely powerful AI computers and that actually running them would be somewhat less power-intensive. That led to some trepidation on Wall Street earlier this year, when DeepSeek claimed that it trained its AI models on below top-of-the-line Nvidia chips. The thinking at the time was that if companies could train and run their AI models on underpowered chips, then there was no need for Nvidia's pricey high-powered systems. But that narrative quickly flipped as chip companies pointed out that those same AI models benefit from running on powerful AI computers, allowing them to reason over more information more quickly than they would while running on less-advanced systems. 'I think there's still a misperception that inferencing is trivial and easy,' Deierling said. 'It turns out that it's starting to look more and more like training as we get to [an] agentic workflow. So all of these networks are important. Having them together, tightly coupled to the CPU, the GPU, and the DPU [data processing unit], all of that is vitally important to make inferencing a good experience.' Nvidia's rivals are, however, circling. AMD is looking to grab more market share from the company, and cloud giants like Amazon, Google, and Microsoft continue to develop their own AI chips. Industry groups also have their own competing networking technologies including UALink, which is meant to go head-to-head with NVLink, explained Forrester analyst Alvin Nguyen. But for now, Nvidia continues to lead the pack. And as tech giants, researchers, and enterprises continue to battle over Nvidia's chips, the company's networking business is all but guaranteed to keep growing as well. Email Daniel Howley at dhowley@ Follow him on X/Twitter at @DanielHowley.
Yahoo
9 minutes ago
- Yahoo
Why Arista Networks Stock Is Skyrocketing Wednesday
Arista Networks Inc. (NYSE:ANET) reported better-than-expected second-quarter financial results after markets closed on Tuesday. Revenues increased 30.4% year over year $2.21 billion, versus estimates of $2.11 billion and the management guidance of $2.1 billion. Adjusted EPS jumped to 73 cents from 53 cents a year ago, versus estimates of 65 cents. Gross margin was 65.2% in the second CFO, Chantelle Breithaupt, said, 'Non-GAAP operating income crossed $1 billion for the first time at Arista...' View more earnings on ANET Arista Networks expects third-quarter sales of $2.25 billion versus the consensus of $2.093 billion. Analysts' Reaction Following the impressive earnings report and upbeat guidance, several prominent financial institutions reiterated their positive stance on Arista Networks. Morgan Stanley maintained an Overweight rating, raising its price forecast from $120 to $125. Piper Sandler, while holding a Neutral rating, significantly increased its price forecast from $89 to $143. UBS and Goldman Sachs both maintained Buy ratings, lifting their price forecasts from $115 to $155. Keybanc upheld its Overweight rating, adjusting its price forecast from $115 to $145, while Evercore ISI Group maintained an Outperform rating, raising its forecast from $120 to $150. Needham also maintained a Buy rating, increasing its price forecast from $130 to $155. Price Action: ANET stock is trading higher by 18.1% to $139.50 at last check Wednesday. Read Next:Photo via Shutterstock Latest Ratings for ANET Date Firm Action From To Mar 2022 Wells Fargo Upgrades Equal-Weight Overweight Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Wells Fargo Maintains Equal-Weight View More Analyst Ratings for ANET View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? ARISTA NETWORKS (ANET): Free Stock Analysis Report This article Why Arista Networks Stock Is Skyrocketing Wednesday originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
Amgen Stock Sinks As Market Eyes MariTide's Next Move
Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that surpassed analyst expectations after markets closed on Tuesday. The US drug maker reported adjusted earnings of $6.02 per share, up 21% year over year, beating the consensus of $5.24. Amgen reported quarterly sales of $9.18 billion, up 9%, beating the Wall Street estimate of $8.87 sales grew 9%, driven by 13% volume growth, partially offset by 3% lower net selling price. Fifteen products delivered at least double-digit sales growth in the second quarter. Outlook Following the strong quarterly performance, Amgen raised fiscal year 2025 adjusted earnings guidance from $20.00-$21.20 per share to $20.20-$21.30 versus the consensus of $20.89. The company raised sales outlook from $34.30 billion-$35.70 billion to $35 billion-$36 billion versus the consensus of $35.29 billion. MariTide in Focus Despite the positive financial results, investor focus remains squarely on the company's experimental weight-loss drug, MariTide. A William Blair analyst noted that investors are 'hyper-focused' on the drug's progress. Part 2 of the Phase 2 chronic weight management study is ongoing in obese patients, with or without type 2 diabetes. Data readout is anticipated in the fourth quarter of 2025. View more earnings on AMGN A Phase 2 study investigating MariTide for type 2 diabetes is ongoing in adults with and without obesity. Data readout is anticipated in the fourth quarter of 2025. Analyst Matt Phipps of William Blair said, 'Given the trial is solely focused on the maintenance setting, we do not believe it will address the key question of tolerability that investors continue to debate.' Analyst Phipps says Amgen shares are up 15% year-to-date, although it remains volatile as investors debate clinical updates with MariTide given the significant market opportunity and competitive landscape. 'We believe Amgen has had meaningful clinical and commercial success with assets including Repatha, Evenity, Blincyto, Tezspire, Imdelltra, and Uplizna that support continued upside on top of the potentially differentiated profile of MariTide, and therefore reiterate our Outperform rating.' Amgen has some near-term headwinds from legacy products, including the recent launch of a biosimilar to Prolia and Xgeva at the end of May 2025 (recent settlement with Sandoz), and the difficulties in gaining more market share with the biosimilar franchises, but the analyst believes clinical catalysts over the next 6 to 12 months will provide meaningful reasons for investor excitement about the long-term growth prospects of the company. Check out . Price Action: AMGN stock is trading lower by 5.10% to $284.97 at last check Wednesday. Read Next:Photo by JHVEPhoto via Shutterstock Latest Ratings for AMGN Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Wells Fargo Maintains Equal-Weight Feb 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for AMGN View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? AMGEN (AMGN): Free Stock Analysis Report This article Amgen Stock Sinks As Market Eyes MariTide's Next Move originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
